Clinical Trials Directory

Trials / Terminated

TerminatedNCT01543607

Endoscopic Therapy of Malignant Bile Duct Strictures

Endoscopic Therapy of Malignant Bile Duct Strictures: A Pilot Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with malignant bile duct stenosis have poor prognosis and most of the patients are not good candidate for surgery at the time of diagnosis. Placement of the stent is the palliative care for these patients. However over 50% of the stents get blocked within 6-8 months. Use of the radiofrequency ablation before the stent placement may improve stent patency. Heat will be applied to the bile duct in order to open the blockage and prevent the re-growth of tissue into the stent. The investigators are looking to see how safe and feasible RFA (Radiofrequency ablation) catheter is in patient with malignant bile duct stenosis.

Detailed description

As part of medical care subjects will be undergoing an endoscopic procedure (ERCP) in order to evaluate and stent a bile duct blockage. During the ECRP and just prior to the stent placement subjects will undergo the placement of a radiofrequency ablation catheter into the bile duct blockage. Heat will be applied to the bile duct in order to open the blockage and prevent the re-growth of tissue into the stent; after the radiofrequency ablation, stent will be placed. Three days after the procedure subjects will receive a phone call from the research coordinator to check any adverse or unwanted effects of the treatment. The study procedure (radiofrequency ablation) takes place over 10 minutes during ERCP. The subjects will undergo routine follow up for their medical problems. No follow up visits are required as part of the study.

Conditions

Interventions

TypeNameDescription
DEVICERadiofrequency ablation catheter (Habib EndoHBP)Catheter placement into bile duct

Timeline

Start date
2012-02-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2012-03-05
Last updated
2017-04-24
Results posted
2017-04-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01543607. Inclusion in this directory is not an endorsement.